PeptiDream Inc. (PPTDF)
PNK: PPTDF
· Real-Time Price · USD
13.53
1.53 (12.75%)
At close: Apr 24, 2025, 3:18 PM
Company Description
PeptiDream Inc., a biopharmaceutical company, engages in the discovery and development of constrained peptides, small molecules, and peptide-drug conjugate therapeutics.
The company develops its products based on its Peptide Discovery Platform System, a drug finding platform for the development of peptides.
It has a collaborative research and exclusive license agreement with Takeda Pharmaceutical Company Limited to develop peptide drug conjugates for neuromuscular diseases.
The company was incorporated in 2006 and is headquartered in Kawasaki, Japan.
PeptiDream Inc.
| Country | JP |
| IPO Date | Aug 20, 2014 |
| Industry | Biotechnology |
| Sector | Healthcare |
| Employees | 621 |
| CEO | Dr. Patrick Crawford Reid Ph.D. |
Contact Details
Address: 3-25-23 Tonomachi Kawasaki, JP | |
| Website | https://www.peptidream.com |
Stock Details
| Ticker Symbol | PPTDF |
| Exchange | PNK |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | n/a |
| CUSIP Number | n/a |
| ISIN Number | JP3836750004 |
| Employer ID | - |
| SIC Code | n/a |
Key Executives
| Name | Position |
|---|---|
| Dr. Patrick Crawford Reid Ph.D. | President, Chief Executive Officer & Representative Director |
| Dr. Kiyofumi Kaneshiro Ph.D. | Chief Financial Officer, Executive Vice President & Director |
| Christian Cunningham Ph.D. | Chief Scientific Officer |
| Masato Murakami M.B.A., M.D., Ph.D. | Chief Medical Officer |
| Yuko Okimoto | IR & Public Relations Director |